상세 보기
Impact of antiplatelet therapy on erectile dysfunction following percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
- Choi, Joongwon;
- Lee, Chung Un;
- Park, Hyun Woong;
- Kim, Jung Hoon;
- Lee, Yong Seong;
- ... Jeong, Young-Hoon;
- 외 7명
WEB OF SCIENCE
0SCOPUS
0초록
Acute myocardial infarction (AMI) is strongly associated with erectile dysfunction (ED). This study evaluated the association between P2Y12 receptor inhibitor type and ED, and factors associated with moderate-to-severe ED in high-risk patients with AMI. The HEALING-AMI trial randomized patients with naïve ST-segment elevation myocardial infarction (STEMI) to dual antiplatelet therapy (DAPT) with either ticagrelor or clopidogrel. This substudy included 59 male patients who completed 6 months of DAPT (ticagrelor, n = 30; clopidogrel, n = 29). Erectile function [International Index of Erectile Function-5 (IIEF-5)], Bleeding Academic Research Consortium (BARC) bleeding, and dyspnoea were assessed using standardized questionnaires. At 6-month follow-up, moderate-to-severe ED (IIEF-5 ≤ 11) and bleeding episodes (predominantly BARC type 1) were observed in 47.5% and 54.2%, respectively. Compared with clopidogrel, ticagrelor was associated with a lower IIEF-5 score (9.7 ± 8.8 vs. 17.0 ± 7.8, p = 0.002) and lower platelet reactivity [32 ± 67 vs. 146 ± 55 P2Y12 reaction units (PRU) measured by VerifyNow, p < 0.001]. Moderate-to-severe ED was more common in patients treated with ticagrelor than in those treated with clopidogrel (63.3% vs. 31.0%). Bleeding episodes and platelet reactivity were also significantly associated with moderate-to-severe ED. In multivariable analysis, both P2Y12 inhibitor type and bleeding episodes were independently associated with moderate-to-severe ED. After multivariable adjustment, ticagrelor-treated patients who experienced bleeding had an approximately 5.6-fold higher odds of moderate-to-severe ED than clopidogrel-treated patients without bleeding (95% CI 1.052-30.087, p = 0.044). In male patients with STEMI, moderate-to-severe ED and bleeding episodes were common during DAPT. P2Y12 inhibitor type (ticagrelor vs. clopidogrel) and bleeding episodes were associated with moderate-to-severe ED. Copyright © 2026 Choi, Lee, Park, Kim, Lee, Ahn, Koh, Kang, Kim, Tantry, Gurbel, Hwang and Jeong.
키워드
- 제목
- Impact of antiplatelet therapy on erectile dysfunction following percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
- 저자
- Choi, Joongwon; Lee, Chung Un; Park, Hyun Woong; Kim, Jung Hoon; Lee, Yong Seong; Ahn, Jong-Hwa; Koh, Jin Sin; Kang, Min Gyu; Kim, Weon; Tantry, Udaya S; Gurbel, Paul A; Hwang, Jin-Yong; Jeong, Young-Hoon
- 발행일
- 2026
- 유형
- Journal Article
- 권
- 13
- 언어
- ENG
- 발행국가
- 스위스
- ISSN
- P 2296-858X